Vinge has advised Irisity AB (publ) in connection with its acquisition of all shares in the Israeli company Agent Video Intelligence Ltd for a purchase price of approximately SEK 580 million.
Vinge has advised Heda Security AB, a Helix Kapital portfolio company, in conjunction with its acquisition of the shares in Sydstängsel i Helsingborg AB.
Vinge has advised Fidelio Capital AB in its majority investment in Hemfrid i Sverige AB, the leading player within the home service industry in Sweden, with a revenue exceeding MSEK 700 and more than 2,000 employees in 2020. The transaction is subject to customary regulatory approvals and is expected to be completed during the second half of 2021.
Vinge has advised Road Rental Scandianvia AB in conjunction with the acquisition of all shares in TB Group AB, which conducts Trafikbutiken and manages traffic facilities with several depots in Mälardalen as well as in Karlskoga and Jönköping.
Vinge advises Calliditas Therapeutics, a specialty pharmaceutical company listed on Nasdaq Stockholm and on The Nasdaq Global Select Market in the US, in connection with a directed share issue whereby the company will raise proceeds of approximately SEK 324 million, before issue costs.
Vinge has advised TransPerfect Global Inc., the world’s leading provider of language and technology solutions for the global market, in connection with the acquisition of Semantix International Group AB, which is the Nordic region’s largest provider of translation and interpreting services.
Vinge advises Ares Management in conjunction with an investment of up to SEK 2,000,000,000 in Gladsheim Fastigheter AB. Ares Management is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, private equity, real estate and infrastructure asset classes.
Qlik® is market leading in the visual data analysis industry. Qlik’s products meet its customers’ growing needs in all areas by way of reports and visual analysis through self‑service to guided, embedded and customised analysis.
Surgical Science Sweden AB, listed on Nasdaq First North Growth Market, has performed a directed new issue of shares valued at approximately SEK 2.7 billion at a subscription price of SEK 210.
